Encapsulated Rapamycin (eRapa)
EMT-FAP-001
Phase 2 small_molecule active
Quick answer
Encapsulated Rapamycin (eRapa) for Familial Adenomatous Polyposis is a Phase 2 program (small_molecule) at Biodexa Pharmaceuticals Plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biodexa Pharmaceuticals Plc
- Indication
- Familial Adenomatous Polyposis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active